Table 3.
PCSM | |||
---|---|---|---|
Variable | HR | 95% CI | p Value |
Age | 0.99 | 0.97–1.02 | 0.96 |
African-American race (versus Caucasian) | 0.53 | 0.27–1.07 | 0.08 |
Number of comorbidities | 1.03 | 0.88–1.21 | 0.69 |
CAPRA score | 1.27 | 1.17–1.37 | <0.001 |
Treatment with RT (versus RP) | 1.43 | 0.97–2.12 | 0.07 |
Receipt of ADT (versus no) | 1.30 | 0.90–1.89 | 0.16 |
Non-PC Death | |||
Variable | HR | 95% CI | p Value |
Age | 1.06 | 1.05–1.08 | <0.001 |
African-American race (versus Caucasian) | 1.34 | 1.03–1.73 | 0.03 |
Number of comorbidities | 1.23 | 1.15–1.32 | <0.001 |
CAPRA score | 0.99 | 0.96–1.04 | 0.98 |
Treatment with RT (versus RP) | 1.26 | 1.07–1.49 | 0.006 |
Receipt of ADT (versus no) | 1.22 | 1.03–1.44 | 0.02 |